N-Ethylhexedrone was patented by the German pharmaceutical business Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1] Because of this a small degree of sample is required for correct outcomes, c